Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alvotech (ALVO) vs HUTCHMED (China) Limited Sponsored ADR (HCM)

Alvotech and HUTCHMED (China) Limited Sponsored ADR are both Drug Manufacturers Specialty & Generic companies. Alvotech and HUTCHMED (China) Limited Sponsored ADR are of similar size ($2.4B and $2.3B). Alvotech grew revenue faster over the last twelve months: 364.3% against 245.2%. HUTCHMED (China) Limited Sponsored ADR has the higher net margin (−23.6% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, HUTCHMED (China) Limited Sponsored ADR leads on 7 and Alvotech on 4.

Valuation

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 5.77 n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.38 12.29
EV/Sales 9.74 (0.13) 2.56
Earnings yield (20.81%) (21.11%) (2.99%)
Free cash flow yield (12.51%) 0.00% 0.00%

Profitability

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 44.40% 53.94%
Operating margin (42.43%) 0.00% 0.00%
Net margin (101.05%) (23.63%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% 245.17% 10.01%
EPS growth (last fiscal year) 111.49% 1,090.91% —
Revenue growth, 5-year CAGR — 19.20% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 0.07 0.05
Current ratio 1.65 5.64 2.31
Net debt to EBITDA 9.71 49.29 0.85

Dividend

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Market cap 2.30b 2.43b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack